{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:34:09Z","timestamp":1788449649363,"version":"build-2803163510"},"reference-count":16,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2026]]},"DOI":"10.70352\/scrj.cr.26-0003","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T22:09:42Z","timestamp":1776463782000},"page":"n\/a","source":"Crossref","is-referenced-by-count":1,"title":["Sustained Complete Remission after Radiofrequency Ablation for Liver Oligometastasis from Pancreatic Cancer despite Persistent Carbohydrate Antigen 19-9 Elevation: A Case Report"],"prefix":"10.70352","volume":"12","author":[{"given":"Yusuke","family":"Takahashi","sequence":"first","affiliation":[{"name":"Department of Digestive Surgery, Nagano Municipal Hospital, Nagano, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Nagano Municipal Hospital, Nagano, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Seki","sequence":"additional","affiliation":[{"name":"Department of Digestive Surgery, Nagano Municipal Hospital, Nagano, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kolbeinsson H, Hoppe A, Bayat A, et al. Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma. Surgery 2021; 169: 649\u201354.","DOI":"10.1016\/j.surg.2020.06.042"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364: 1817\u201325.","DOI":"10.1056\/NEJMoa1011923"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013; 369: 1691\u2013703.","DOI":"10.1056\/NEJMoa1304369"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Maisey NR, Norman AR, Hill A, et al. CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials. Br J Cancer 2005; 93: 740\u20133.","DOI":"10.1038\/sj.bjc.6602760"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) George B, Kent M, Surinach A, et al. The association of real-world CA 19-9 level monitoring patterns and clinical outcomes among patients with metastatic pancreatic ductal adenocarcinoma. Front Oncol 2021; 11: 754687.","DOI":"10.3389\/fonc.2021.754687"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Halm U, Schumann T, Schiefke I, et al. Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer. Br J Cancer 2000; 82: 1013\u20136.","DOI":"10.1054\/bjoc.1999.1035"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ziske C, Schlie C, Gorschl\u00fcter M, et al. Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine. Br J Cancer 2003; 89: 1413\u20137.","DOI":"10.1038\/sj.bjc.6601263"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Isaji S, Mizuno S, Windsor J, et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology 2018; 18: 2\u201311.","DOI":"10.1016\/j.pan.2017.11.011"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Lee SJ, Kim JH, Kim SY, et al. Percutaneous radiofrequency ablation for metachronous hepatic metastases after curative resection of pancreatic adenocarcinoma. Korean J Radiol 2020; 21: 316\u201324.","DOI":"10.3348\/kjr.2019.0647"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Saito R, Ban D, Mizui T, et al. Oligo-like liver metastasis: a novel prognostic indicator to improve survival in pancreatic cancer. Ann Gastroenterol Surg 2023; 8: 481\u20139.","DOI":"10.1002\/ags3.12753"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Elias D, Di Pietroantonio D, Gachot B, et al. Liver abscess after radiofrequency ablation of tumors in patients with a biliary tract procedure. Gastroenterol Clin Biol 2006; 30: 823\u20137.","DOI":"10.1016\/S0399-8320(06)73327-9"},{"key":"12","unstructured":"12) Iida H, Aihara T, Ikuta S, et al. Risk of abscess formation after liver tumor radiofrequency ablation: a review of 8 cases with a history of enterobiliary anastomosis. Hepatogastroenterology 2014; 61: 1867\u201370."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nakata K, Miyasaka Y, Ishizawa T, et al. Patients with pancreatic cancer with synchronous liver oligometastasis show a significant long-term survival benefit from resection under specific conditions: a multicenter national cohort study. J Hepatobiliary Pancreat Sci 2025; 32: 611\u20139.","DOI":"10.1002\/jhbp.12181"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Brierley JD, Gospodarowicz MK, Wittekind C, editors. TNM Classification of Malignant Tumours, 8th ed. Oxford: Wiley-Blackwell; 2017.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Takayama T, Hasegawa K, Izumi N, et al. Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF trial). Liver Cancer 2021; 11: 209\u201318.","DOI":"10.1159\/000521665"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) van der Lei S, Puijk RS, Dijkstra M, et al. Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial. Lancet Oncol 2025; 26: 187\u201399.","DOI":"10.1016\/S1470-2045(24)00660-0"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.26-0003\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:09:41Z","timestamp":1776485381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.26-0003\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.26-0003","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"cr.26-0003"}}